Display options
Share it on

ACS Med Chem Lett. 2015 Feb 06;6(4):402-7. doi: 10.1021/ml500464f. eCollection 2015 Apr 09.

F-18 Labeled RGD Probes Based on Bioorthogonal Strain-Promoted Click Reaction for PET Imaging.

ACS medicinal chemistry letters

Hye Lan Kim, Kalme Sachin, Hyeon Jin Jeong, Wonsil Choi, Hyun Soo Lee, Dong Wook Kim

Affiliations

  1. Department of Nuclear Medicine, Chonbuk National University Medical School , Jeonju, Jeonbuk 561-712, Korea.
  2. Department of Chemistry and Chemical Engineering, Inha University , 100 Inha-ro, Nam-gu, Incheon 402-751, Korea.
  3. Department of Chemistry, Sogang University , Seoul 121-742, Korea.

PMID: 25893040 PMCID: PMC4394342 DOI: 10.1021/ml500464f

Abstract

A series of fluorine-substituted monomeric and dimeric cRGD peptide derivatives, such as cRGD-ADIBOT-F (ADIBOT = azadibenzocyclooctatriazole), di-cRGD-ADIBOT-F, cRGD-PEG5-ADIBOT-F, and di-cRGD-PEG5-ADIBOT-F, were prepared by strain-promoted alkyne azide cycloaddition (SPAAC) reaction of the corresponding aza-dibenzocyclooctyne (ADIBO) substituted peptides with a fluorinated azide 3. Among these cRGD derivatives, di-cRGD-PEG5-ADIBOT-F had the highest binding affinity in a competitive binding assay compared to other derivatives and even the original cRGDyk. On the basis of the in vitro study results, di-cRGD-PEG5-ADIBOT-(18)F was prepared from a SPAAC reaction with (18)F-labeled azide and subsequent chemo-orthogonal scavenger-assisted separation without high performance liquid chromatography (HPLC) purification in 92% decay-corrected radiochemical yield (dcRCY) with high specific activity for further in vivo positron emission tomography (PET) imaging study. In vivo PET imaging study and biodistribution data showed that this radiotracer allowed successful visualization of tumors with good tumor-to-background contrast and significantly higher tumor uptake compared to other major organs.

Keywords: F-18 labeling method; PET molecular imaging; RGD peptide; copper-free click chemistry; fluorine-18; radiopharmaceuticals; tumor angiogenesis

References

  1. Bioconjug Chem. 2012 Aug 15;23(8):1680-6 - PubMed
  2. Mol Pharm. 2006 Sep-Oct;3(5):472-87 - PubMed
  3. Mol Pharm. 2014 Feb 3;11(2):505-15 - PubMed
  4. J Nucl Med. 2006 Jan;47(1):113-21 - PubMed
  5. Nat Med. 1995 Jan;1(1):27-31 - PubMed
  6. Angew Chem Int Ed Engl. 2008;47(47):8998-9033 - PubMed
  7. Angew Chem Int Ed Engl. 2011 Nov 18;50(47):11117-20 - PubMed
  8. Chem Rev. 2010 May 12;110(5):3087-111 - PubMed
  9. Bioconjug Chem. 2004 Jan-Feb;15(1):61-9 - PubMed
  10. Mol Imaging Biol. 2010 Oct;12 (5):530-8 - PubMed
  11. ACS Med Chem Lett. 2011 Oct 07;2(12):885-9 - PubMed
  12. Nat Rev Cancer. 2002 Sep;2(9):683-93 - PubMed
  13. Eur J Nucl Med. 2001 Jul;28(7):929-38 - PubMed
  14. Angew Chem Int Ed Engl. 2008;47(12):2253-5 - PubMed
  15. Org Biomol Chem. 2011 Nov 7;9(21):7393-9 - PubMed
  16. Nat Med. 2000 Apr;6(4):389-95 - PubMed
  17. Nucl Med Mol Imaging. 2010 Apr;44(1):25-32 - PubMed
  18. Bioconjug Chem. 2011 Dec 21;22(12 ):2415-22 - PubMed
  19. Chem Commun (Camb). 2010 Jan 7;46(1):97-9 - PubMed
  20. Chem Rev. 2008 May;108(5):1501-16 - PubMed
  21. Genes Dev. 2003 Mar 1;17(5):545-80 - PubMed
  22. Semin Oncol. 2002 Dec;29(6 Suppl 16):15-8 - PubMed
  23. Bioconjug Chem. 2009 Dec;20(12 ):2199-213 - PubMed
  24. Acc Chem Res. 2011 Sep 20;44(9):666-76 - PubMed
  25. Nucl Med Biol. 2004 Jan;31(1):11-9 - PubMed
  26. Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9226-33 - PubMed
  27. Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1823-31 - PubMed
  28. Bioconjug Chem. 2007 Nov-Dec;18(6):1987-94 - PubMed
  29. Mol Imaging. 2004 Apr;3(2):96-104 - PubMed
  30. Hematol Oncol Clin North Am. 2004 Oct;18(5):991-1006, vii - PubMed
  31. Acc Chem Res. 2009 Jul 21;42(7):969-80 - PubMed
  32. Angew Chem Int Ed Engl. 2013 Sep 27;52(40):10549-52 - PubMed
  33. J Am Chem Soc. 2006 Dec 20;128(50):16394-7 - PubMed
  34. J Am Chem Soc. 2009 Nov 4;131(43):15769-76 - PubMed

Publication Types